Days Inventory is also known as Days Sales of Inventory (DSI). Halozyme Therapeutics's Average Total Inventories for the
three
months ended in Dec. 2023 was $128.3 Mil. Halozyme Therapeutics's Cost of Goods Sold for the
three
months ended in Dec. 2023 was $52.3 Mil.
Hence, Halozyme Therapeutics's Days Inventory for the
three
months ended in Dec. 2023 was 223.79.
The historical rank and industry rank for Halozyme Therapeutics's Days Inventory or its related term are showing as below:
HALO'
s Days Inventory Range Over the Past 10 Years
Min: 99.19 Med: 205.05 Max: 500.02
Current: 226.4
During the past 13 years, Halozyme Therapeutics's highest Days Inventory was 500.02. The lowest was 99.19. And the median was 205.05.
HALO's Days Inventory is ranked worse than 55.54% of 650
companies
in the Biotechnology industry
Industry Median: 191.745
vs HALO: 226.40
Halozyme Therapeutics's Days Inventory
increased
from Dec. 2022 (220.32) to Dec. 2023 (223.79).
It might indicate that Halozyme Therapeutics's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Halozyme Therapeutics's Inventory Turnover for the
three
months ended in Dec. 2023 was 0.41.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Halozyme Therapeutics's Inventory-to-Revenue for the
three
months ended in Dec. 2023 was 0.56.
Halozyme Therapeutics Days Inventory Historical Data
The historical data trend for Halozyme Therapeutics's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Halozyme Therapeutics's Days Inventory
For the Biotechnology subindustry, Halozyme Therapeutics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Halozyme Therapeutics's Days Inventory Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Halozyme Therapeutics's Days Inventory distribution charts can be found below:
* The bar in red indicates where Halozyme Therapeutics's Days Inventory falls into.
Halozyme Therapeutics Days Inventory Calculation
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Halozyme Therapeutics's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Halozyme Therapeutics (NAS:HALO) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Halozyme Therapeutics's Inventory Turnover for the
three
months ended in Dec. 2023 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Halozyme Therapeutics's Inventory to Revenue for the
three
months ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Halozyme Therapeutics Days Inventory Related Terms
Thank you for viewing the detailed overview of Halozyme Therapeutics's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Halozyme Therapeutics (Halozyme Therapeutics) Business Description
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HALO has been successfully added to your 